| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 314,692 | 307,111 | 487,470 | 447,461 | | Cost of Revenue | 262,708 | 223,803 | 397,242 | 563,074 | | | Gross Profit | 51,984 | 83,308 | 90,228 | (115,613) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,703 | 23,856 | 23,021 | (183,353) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,527 | 1,370 | 1,362 | 23,712 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,754 | 58,082 | 65,845 | 44,028 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 153 | (210) | (560) | (559) | | Earnings Before Interest And Taxes | 23,907 | 57,872 | 65,285 | 43,469 | | Interest Expense | 15,326 | 15,963 | 16,398 | 15,903 | | Income Before Tax | 8,581 | 41,909 | 48,887 | 27,566 | | Income Tax Expense | (53) | 15,619 | 17,468 | 10,081 | | Minority Interest | (1,325) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,309 | 26,290 | 31,419 | 17,485 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,309 | 26,290 | 31,419 | 17,485 | | Preferred Stock And Other Adjustments | 830 | (437) | (393) |
-
| | | Net Income Applicable To Common Shares | $8,139 | $25,853 | $31,026 | $17,485 |
|
0.29% Nasdaq 
Income Statement
